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Dr. David M . Hume (Stuart McGuire Professor, and chairman , department of surgery, Medical College
of Virginia, Richmond): I'd like to begin by asking Dr. Doolan a question.
Do you have any special technique or
criterion, Dr. Doolan, for determining
the reversibility of disease in a patien t that is being dialyzed for acute
renal shutdown? That is to say, how
do you decide whether to turn the
dialysis off after several days?
Dr. Paul D. Doolan (director, clinical investigation department, N aval
Medical Research Institute, Bethesda,
Maryland) : I don't know if I understand this question .
Dr. Hume: Well , suppose you've got
a patient with acute shutdown and you
have dialyzed him, because you had to
keep him going. How do you decide
whether this patient is going to "open
up" sometime on his own ; how long
do you keep dialyzing him if you don't
have a chronic program, and when do
you decide that the shutdown is irreversible?
Dr. Doolan: If he's got acute renal
fa ilure, I don't know whether you can
ever say it's irreversible. This question
seems to emerge when you have shutdowns of unknown origin, and you
are wondering about whether the person doesn't have acute glomerulonephritis, for example. If the y don't open
up in less than 30 days, then the likelihood of their opening up is very remote.
Dr. Hume: How do you decide they
have got acute glomerulonephritis?
Dr. Doolan: Well, I think history
and clinical appraisal is all I know of.
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If an adult is shutdown with acute
glomerulonephritis, the prognosis is
poor. I think it varies among different
people as to when you feel justified in
doing renal biopsy to see whether or
not this will help you with making the
decision of whether to continue dialysis. I would say that, in my own experience, renal biopsies have not
helped.
Dr. Hume: Anybody else on the
panel want to comment on this question?
Dr. John E. Kiley (professor of
medicine, Albany Medical College,
Albany, New York): I think when you
see a patient with acute renal failure
that does not open up after two or
three weeks, you begin to see a somewhat characteristic behavior on the
part of the physician handling the case.
What we tend to do, first, is to support
the patient by dialytic means, hoping
that diuresis will ensue. But once you
go into the second or third week, one
certainly begins to feel pushed. After
having eliminated any obstructive
uropathy (by cystoscopic examination,
etc.), we then do a renal biopsy. And,
although there are some contraindications to doing a biopsy, it has been
helpful in revealing a disease condition that we had not suspected, e.g.,
glomerulonephritis, overwhelming pyelonephritis, and infarction of the kidney. These conditions tend to make
one turn off the dialyzer, because this
is not acute tubular necrosis, and the
kidney will not regenerate. The other
thing to do would be to put a catheter
up by way of the femoral artery to the
level of the renal artery and inject a
radioopaque dye. In this way, one can
study the vascularity of the kidney. In
some instances we have discovered
that there has been bilateral infarction
which we didn't suspect. This usually
occurs when the patient has infarcted
one kidney, say a year or two earlier,
without its being clearly diagnosed,
and later the patient has infarcted the
other kidney. So, renal biopsy and
pyelography can be helpful, when, after a month of dialysis you're beginning
to wonder whether you are not rapidly
going into chronic dialysis, inadvertently. Perhaps someone else on the
panel has had more experience than

I with the use of the newer diagnostic
techniques of infusion pyelography.
Dr. Hume: Some patients don't
"open up" for 60 days. The question
is, at the end of 30 days, what do you
do?
Dr. Belding H . Scribner (chief, division of kidney disease, department
of medicine, University of Washington,
Seattle): We're obviously confronted
with this problem continually, because
we do have a chronic program that is
full. But at the same time, we are in
a very serious dilemma in this kind
of situation. I underscore completely
what John Kiley says about the use
of the biopsy at the 30-day point, so
to speak. The other side of the coin
here is, if you do find normal glomeruli
and tubular necrosis at 30 days, then
you are committed to keep the patient
going on dialysis indefinitely. I know
of one patient from Stanley Sheldon's
group in England that went 90 days
with tubular necrosis and then opened
up. So, on the hopeful side, if you do
come up with this diagnosis on renal
biopsy, even in the presence of anuria,
then you are obliged to go on. If you
are worried about the vasculature, I
think the aortogram may be done in
60 days or 90 days, if you are still
"sitting" on the case. I can not elucidate the question Dr. Kiley raised
about the newer radiographic techniques.
Dr. Joseph H . Magee (director of
renal section, department of medicine,
Medical College of Virginia)1 • I want
to allude to what Dr. Scribner just
said. One of the abstracting journals
had reported two cases of cortical infarction, where dial ysis was carried
out for 70 to 80 days before recovery.
The authors believed that some onesixth or one-fifth of nephrons, which
are juxtamedullary, will come back
and function if you dialyze them long
enough. So I wonder if you aren't on
the griddle for about two to three
months, where shock or cortical infarction might h ave been the cause of
shutdown.

At present, assistant professor of
medicine, Jefferson Medical College,
Philadelphia.
1

Dr. Hume: Would anybody on the
panel like to tell about his experience
with the use of large quantities of
contrast material, or would anybody
like to comment on the use of radioactive materials, renal scans or radiorenograms, as assists in determining
whether renal artery thrombosis bas
occurred-Dr. Kiley?
Dr. Kiley: Well, of course, I can't
see how the use of radioactive substances is going to help you, because
they don't really reflect the blood flow ,
but rather the ability of the tubular
cells to concentrate and excrete the
isotope. These p atients may have
neither blood flow nor secreting cells,
so I would not be enthusiastic about
these procedures.
Dr. Hume: If you have neither
blood flow nor kidney cells, you
wouldn't get any uptake, but if you
have got some uptake, then that would
be some evidence of vascularity.
Dr. Kiley: If you're looking for
vascularity, I still think that renal
angiography would be beter than isotopes.
Dr. Hume: Dr. Kiley, in your earlier
discussion (paper on artificial dialysis
in adults), you talked about using dialysis for hypercalcemia. I am wondering if you would advocate this form of
therapy in hypercalcemic crisis, rather
than operating on a patient who has
hyperparathyroidism and hypercalcemic crisis, and removing his parathyroid adenoma. Another condition
I noticed on your list was ammonia intoxication, and I wonder how your
results have been with this.
Dr. Kiley: Well, first, I'll put my
guard up by saying that at that time I
was showing a list of situations which
have been recorded as successfully
treated by dialysis. Now, with hypercalcemia, we have an interesting situation there. I have not personally treated
a hypercalcemic crisis by dialysis, so
I am in no position to disagree with
Dr. Glenn's2 statement that parathyroidectomy is preferable. However, as

2 Dr. James F. Glenn, professor and
chairman, department of urologic surgery,
Duke University, had spoken earlier on
surgery in the prevention of uremia.
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a surgeon, I would like to strike back
by asking you if this would not be an
extremely difficult type of emergency
operation. The hypercalcemia may be
due to hyperactivity of the parathyroid,
which is deeply situated within the
body. I think the complexity and difficulty of this surgery is at least a factor
suggesting that dialytic therapy might
be more efficacious; it is certainly more
straightforward. How do you feel
about this operation itself?
Dr. Hume: We have not had much
experience with this. We had one patient who we thought had this problem.
He certainly had a hypercalcemic
crisis, and we dialyzed him for a
short while, with some fall in calcium,
although its level did not fall strikingly.
We then took the patient to the operating room, explored the neck and then
made the diagnosis of widespread
metastatic disease, which hadn't shown
up in x-rays. The patient ultimately
died of malignant disease. Dr. Magee,
do you recall that patient? I've forgotten exactly what the results of dialysis were.
Dr. Magee: I think we got calcium
down from about 20 to 18. We just
dialyzed for minimum number of
hours and weren't getting anywhere
and proceded with the operation.
Thomas and co-workers 3 in a review of
about 14 such cases, said they believed
the thing to do was to get them right
up to the operating table, because you
just can't dialyze fast enough.
Dr. Kiley: Well, I would disagree
with that. I think that if you are equating a good operation with relatively
poor therapy, that certainly is true,
but I also think that there are better
medical ways of managing this disorder than by dialysis. As a matter of
fact, I think dialysis may be weak,
because you are dealing with a double
equilibrium caused by abnormal parathyroid hormone, so you will have
calcium coming out of the skeleton
just about as rapidly as you can dialyze
it out. On the other hand, by the use

3 Thomas, W. C., Jr., J . G . Wiswell,
T. B. Connor, and J.E. Howard. Hypercalcemic crisis due to hyperparathyroidism . Am. J. Med. 24: 229-239, 1958.

of sulphate and citrate, and, at least
theoretically, EDTA, you can cut down
considerably on the amount of ionized
calcium that is present. This kind of
medical therapy, although a temporary
measure, can give you a good deal of
time, even in the middle of the night,
to prepare the patient and the operating room for surgery. And it can forestall the disaster that sometimes occurs
with sudden death. So, I wouldn't minimize the usefulness of the right kind of
medical therapy.
Dr. Doolan: I don't know whether it
was a tribute to Dr. Kyle, my old boss,
but I never saw a hypercalcemic crisis
with hyperparathyroidism, and he h ad
only a few cases. I have seen hypercalcemic crises with metastatic bone disease. This is the case in which you are
not worried about operating. You can
lower calcium by giving these people
steroids, or you can lower it by doing
peritoneal lavage, and, if you want
to, you can put EDTA in the peritoneal lavage solution and remove even
more calcium that way.
Dr. Hume: That's a good thought.
Actually, there have been about 40 of
these reported in the literature and
the mortality is about 50 %.
Dr. Doolan: With the hyperparathyroid?
Dr. Doolan: Yes.
Dr. Magee: And there are a lot more
now.
Dr. Doolan: Well, my only point
was, they're not all surgical.
Dr. Hume: No, not right away. We
get them in the end, though, because
there is no medical cure for hyperparathyroidism.
Dr. Doolan: The discussion has
spun around how fast the patient with
hypercalcemia should get to the operating room. But, what about the
hypercalcemia that is not due to hyperparathyroid?
Dr. Hume: Well, we don't take those
to the operating room.
Dr. Doolan: This is why I mentioned
peritoneal lavage, steroids, and EDTA
in the peritoneal lavage solution.
Dr. Hume: It is true that the majority of the hypercalcemic crises that
we have seen here have been due to
carcinoma of the breast, and we usually treat those with steroids to get

them off the hook. Now, Dr. Kiley, I
would like to ask you about dialysis
in ammonia intoxication.
Dr. Kiley: We demonstrated quite a
few years ago that the ammonia ion
is very efficiently removed by a dialyzer, and we have used this with some
gratifying results in about half a dozen
patients. The thing I want to emphasize is that I don't believe at all that
this is effective clinical use of dialysis.
Ammonia toxication is almost invariably handled better by other approaches.
Dr. Hume: Were these people in
hepatic coma, or were they people who
had ingested some household detergent?
Dr. Kiley: The patients who were
successfully treated were patients with
portal cirrhosis who were getting along
quite well, who then had a massive
gastrointestinal hemorrhage. The hemorrhage was then stopped one way
or another, but they went into ammonia intoxication from digestion of
the blood in the gastrointestinal tract,
and they were benefited by the removal
of this excess ammonia. But I think
this has very little practical general
clinical worth.
Dr. Hume: Dr. Kiley, when I was
an intern and resident, we used to see
patients with various types of renal
shutdown and potassium intoxication.
In those days, a major indication for
dialyzing a patient was potassium intoxication. We used to go scurrying
around trying to get the patient just
on the razor's edge, watching for EKG
changes of potassium intoxication. And
we were in sort of a sweat to see
whether he was going to survive, and
to judge the right moment to put him
on the kidney. Now you suggest in
your talk that we ought to get an EEG
instead of an EKG, to decide when to
put the patient on the kidney. This is
harder to get than an EKG, and it is
somewhat more difficult to interpret.
Do you really feel that this is the way
to decide when to put a patient on the
kidney?
Dr. Kiley: Well, first of all, let us be
clear that the EEG has nothing to do
with potassium intoxication. Although
I was possibly skipping along to catch
up a little time, I did preface my slide
of the EEG with the statement that
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it was not generally available. And I
would agree with your comment that,
were this to be efficiently used, it must
become more available clinically, and
I think we must work more to that end.
We have it fairly available now because this is a particular interest of
ours. We have a portable EEG machine which can be taken to the ward,
and you can count the frequency of
the waves per second as they come off
the machine. So, the EEG can become
clinically useful, and I think it is
something we must progress with.
Really, what we are striving for here
is a relatively simple electronic counter
which will sort the seconds into two
stacks; those in which the wave frequency of the EEG is above six and
those in which the wave frequency is
below six. The latter is a clearly abnormal situation. I do think that all
of us are now using the EKG for potassium intoxication, particularly since
the cardioscope has become generally
available. If we have a potassium problem, we move the cardioscope into
the room and turn it on and monitor
the EKG continuously.
Dr. Hume: I was wondering, since
Dr. Scribner has demonstrated that
dialysis is so easy to do in the basement, why don't you simply dialyze the
patients repeatedly when they have
uremia, rather than rely on some particular danger signal to put them on
dialysis?
Dr. Kiley: I think you're quite right,
and I think that this is where we should
be going. And, we should be using
the artificial kidney and other dialyzers
more as the human kidney, to preserve
normalcy, rather than to correct a very
abnormal situation. But I think that, in
the present state of our knowledge, the
main question is just how much dialysis is ideal. We just don't know that,
because we have not yet correlated the
changes in metabolism, particularly
nitrogen metabolism, with these physiological changes. The thing I like
about the EEG is that for the first time,
we have something reasonably objective in altered physiology which we can
use in clinical uremia. I was all sort of
up-in-the-air in clinical uremia because
we usually stood at the foot of the
bed and looked at the patient, and

wondered how sick he was, and that is
hard to go on.
Dr. Hume: Dr. Finberg, I wonder if
in the course of dialysis for poisons of
one sort or another you ever see a rebound phenomenon after the dialysis
is done. That is, the patient wakes up
from dialysis and then, sometime later,
he lapses back into coma. Has this
ever been a problem?
Dr. Laurence Finberg (chief, division of pediatrics, Montefiore Hospital, and professor of pediatrics, Albert Einstein College of Medicine, New
York): In most of the common poisonings that we see that is not a problem.
There are some poisonings in which
that has been notoriously reported to
be the case. Then, you have to go back
and dialyze again.
Dr. Hume: Dr. Finberg, supposing
you have a problem, as occasionally
comes up, that a child is born without
kidney function. Is there any effective
way to dialyze the newborn baby, or
otherwise to manage the problem?
Dr. Finberg: Yes, I think there are
two comments pertinent to this question. One is that the infant is probably
the only living organism that can survive without any renal function at all,
and without any artificial aid, for long
periods of time. The record is up to six
weeks. This is because the infant is so
rapidly growing that if the absence of
urine formation is not a consequence
of some kind of disease which in itself
induces katabolism, he will grow, and
will so expand his body fluid compartments that they can actually hold the
toxic substances in them in so dilute
a form as to permit growth. This will
be true if the infant is on the proper
feed , and the ideal feed for this is
human-breast milk. And that is how
the record was set. The mother took
her baby home, who subsequently
turned out to have no renal mass at
all. She didn't bring him to the hospital, not thinking it was terribly important that he hadn't put out any
urine, until he was almost six weeks
old. As for dialysis in infants, you can
dialyze small infants if they have an
abdominal cavity that is approachable.
You can do it with peritoneal dialysis,
of course, and this is what we talked
about before. I am told the McNeal-

Collins kidney can be adapted for
small infants, but I haven't actually
seen it in action myself. The other,
larger devices are almost impossible to
use on a small infant, even with trying
to cut down the coil area and exteriorized blood volume.
Dr. Hume: Has anybody on the
panel dialyzed a child under two years
of age?
Dr. Scribner: Dr. Robert Hickman,
in the department of pediatrics in Seattle, has been working on the problem.
It seems to me the number-one requirement for infant dialysis is a small
stable external circuit. I think Dr.
Hickman has dialyzed a child only
four weeks old, and he is using the Kiil
half-length, one-layer unit, with a completely rigid external circuit, and no
blood pumps. It is about a quarter the
size of the unit we use for adults. If
you fully prime the external circuit,
the infant's vasculature cannot tell
when he is on or off the dialyzer. The
big problem in dialysis is to shift the
blood from the equipment to the small
child and back again. With a small
rigid external circuit, we've had good
luck in infant dialysis.
Dr. Hume: Do you put the child
on a set of scales to be sure how much
weight he is gaining or losing?
Dr. Scribner: It isn't necessary unless you're filtering large amounts of
salt solution and then, of course, it's
very helpful to have him on a scale. As
far as the blood shift is concerned, if
you have a rigid external circuit that is
small and fully primed, there's no
problem with bloodshift.
Dr. Hume: Dr. Magee, I wonder if
you want to comment on some of the
things Dr. Scribner has mentioned
briefly, that is, the medical management of a patient with chronic uremia
who is not yet ready for dialysis?
Dr. Magee: Picking out some of the
things the speakers have brought up
today, the common situation now is
that practically no uremic patient
comes in on the ward about whom
you are not asked whether there is
some reversible feature. Twenty-five
years ago there were no nephrologists
because there was nothing for them to
do. Most people didn't believe for 100
years after Bright's description of
15

PANEL ON THE MAINTENANCE OF LIFE IN UREMIA

uremia that there was any such thing
as reversible uremia. The things that
seem to have come along to have
changed all this were: 1) Weiss and
Parker• showed that pyelonephritis was
a common cause of chronic uremia.
They picked out, retrospectively, a lot
of reversible cases that came in with
a pericardia! friction rub or uremic
frost, and then left the hospital. Some
of the older physicians didn't think
they'd ever seen this but here there were
some cases. 2) The salt-losing nephritis
emphasized by Thorne and colleagues';
when the patients went into shock,
instead of giving them adrenocortical
hormones you only had to give salt.
3) Then along came the exponential
growth of blood banks and non-exponential growth of technicians and we
had a large number of transfusion reactions. A lot of younger fellows really
got going from the encouraging experience of bringing some of these
patients through. These easy ones are
not seen any more, but they just reinforced the concept of reversible uremia. 4) W. J. Kolff's book, New Ways
of Trea ting Uremia ,6 which had the
artificial kidney in it, but most importantly, it h ad the high-caloric, lowprotein feedings and the protein-sparing feeding, and the necessity of
restricting water, to avoid pulmonary
edema. 5) And then came the electrocardiogram and the flame photometer,
which helped tell us when the potassium is elevated.
Dr. Hume: I would like to make a
couple of comments relative to Dr.
Scribner's talk comparing chronic dialysis and transplantation, and then
ask him to comment on my remarks.
In the first place, I think we all ought
to admit right off the bat that some
form of chronic dial ysis is essential

' Weiss, S., and F. Parker, Jr. Pyelonephritis: its relation to vascular lesions
and to arterial hypertension. Medicine 18:
221-315, 1939.
5
Thorn, G. W., G. F . Koepf, and M.
Clinton, Jr. Renal failure simulating
adrenocortical insufficiency. New Engl.

l . Med. 231 : 76-85, 1944.
6
Kolff, W. J. New Ways of Treating
Uremia . London: J. and A. Churchill,

Ltd.
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to any transplant program. That is,
without Dr. Scribner's help, and without the use of his device, our own
program might never have gotten off
the ground. Secondly, transplantation
is not a therapeutic program at the
present time; it is an investigative program. It's difficult to talk to Dr. Scribner without being challenged by him,
because he regards chronic dialysis as
a therapeutic program. This immediately puts you on the defensive. So,
I'd like to point out the insufficiencies
of chronic dialysis, and correct a few
figures that have been given about
transplantation. 1) The patients who
were cared for by him for chronic
dialysis were a highly select group of
intelligent people. It is not everybody
who can go down in his basement and
dialyze himself. At least % of the patients we have done transplants on,
not only couldn't dialyze themselves,
they barely had the intelligence to void!
Our overall objective has not been to
see what percentage of survival we
can get, but what we can learn about
transplantation. 2) Chronic dial ysis is
pretty much out with respect to children because it does interfere with
growth and sexual maturity, as Dr.
Scribner has said. 3) The number of
patients who can be benefited by
chronic dialysis is very small. Suppose
for a moment that you were to take
the point of view that the present
objective of either of these two methods is to keep the greatest number of
people alive. (Although this is not the
point of view that we take, it is the
point of view that Dr. Scribner takes.)
In his own setup in Seattle, Washington, he has had six patients on hemodialysis in a five-year period; five of the
six patients are still living. He's done
six patients on peritoneal dialysis ; five
of these patients are still Jiving. And
he's got two patients in their basements. That's a total of 12 patients in
five years, who are living who would
otherwise have died. Our own program
of transplantation h as been going only
two years. We have 28 patients Jiving
who would otherwise have died . None
of Dr. Scribner's patients is cured ; they
all still have their disease. None of his
patients is really well, but this is not
true of any of the transplant patients

either. 4) Hypertension does occur in
patients with chronic renal disease,
even in those on · a low-salt diet. We
have seen this in two instances out of
the 50 patients we've had on chronic
dialysis. Dr. Scribner hasn't seen it in
his six patients, but it does occur, and
it is a problem and one that you cannot solve with dialysis but you can
solve with transplantation. 5) The degrees of independence of the two type~
of patients, that is, the patient with
kidney transplant and the patient on
dialysis, are quite different. Even if
dialysis is done in the basement, and
even if you can dialyze yourself at
night while you sleep, it does encroach
upon your independence to a greater
extent than does the normally functioning kidney transplant in a well patient.
6) None of the patients on chronic dialysis really ever regain their pre-sickness weight. They do regain some
weight, but they never are as healthy
as the patients with good transplants,
although not all patients with transplants have good ones. 7) Almost all of
the patients on chronic dialysis require blood transfusions which are
expensive and dangerous. 8) Neuropathy is almost never corrected by
chronic dialysis-hemodialysis, that is.
9) The mortality figures are somewhat
misleading. If you take Dr. Scribner's
figures and show them on a slide today,
71 % of the patients on chronic dialysis
are now surviving. This figure is not
too different from the figure for the
larger series of transplant patients.
Sixty-two per cent of all the patients
we have done from the very first one
are surviving. Of all transplants from
related donors in the three largest
groups in the country, 73 % are surviving. Of our own cadaver transplants,
70 % are surviving; and if we took only
our last eight months' cases-93 % of
those are surviving. Even if we took all
the patients we did in the first year,
all of whom are now one or two years
post-transplant, 46 % are still living.
Four of the first six patients we did are
still living, and the two that died, died
of total body radiation, which we no '
longer use. Virtually all of our patients
have been on chronic dialysis before
transplantation, ana au or mem preter
the transplant to chronic dialysis. The
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figures which Dr. Scribner quoted, i.e.,
that 70 % of identical twins who could
have lived five years had died of the
disease of the host, are figures that
were reproduced in a recent editorial,'
and are incorrect. The facts are 80%
of all twins done in the last 10 years
are living at present. Although it has
been reported that occasionally either
the twin kidney or a homografted
kidney has developed the disease of the
host, this has not happened as a rule,
and it has not happened in any of our
homotransplants or any of those in
Denver. There's something more than
100 cases in this combined series, so,
I think it must be extremely rare. He
quoted Dr. Don Thomas' thoughts,
namely, that he figures that 5 to 20%
of patients who were transplanted had
a chance of living two years, and that
less one percent of them had a chance
of living for four years. Dr. Thomas
has recently moved to Seattle and it
is understandable that he would have
these thoughts. Dr. Scribner is a very
convincing fellow. Had Dr. Thomas
thought otherwise he might be carried
away in the middle of the night. The
actual figures from the largest series
in the country are that, of those patients who could have lived from one
to two years, 40 to 45 % are living.
Of our own patients who could have
lived for two years, which is a very
small group, 50% are still Jiving. Dr.
Scribner also says that the dialysis program works without doctors. But the
patient with basement kidney must
have about $1,500 a year in professional fees. Furthermore, in our own
dialysis unit, which is modeled after
Dr. Scribner's, Dr. Bower hasn't had
a vacation in a year. Even though our
program is run by nurses and technicians, Dr. Bower doesn't leave town
for any length of time. I would like to
conclude these remarks by saying there
is really no competition between
chronic dialysis and transplantation because the goals of the two are vastly
different. But, I think if there is going

7 Elkinton, T. Russell. Moral problems
in the use of borrowed organs. artificial
and transplanted. Annals int. Med. 60:

309-313 , 1964.

to be an ultimate solution to the problem, that the patient with a normally
functioning kidney, urinating in a normal fashion, with a completely normal
life, who feels perfectly well, and has
regained his pre-sickness weight, is in
a little better situation than the fellow
with a home kidney in the basement.
Dr. Scribner, would you like to comment on this?
Dr. Scribner: I guess we could stay
around a couple of hours and really
have at it, but time is over already.
I'll just make one or two brief remarks. We only had 12 patients at the
University of Washington because it
was not our job to take all the patients
that could come our way. Our job was
to demonstrate the feasibility of the
method, to get on with the job of doing research to improve the method,
and to learn all we could about the
biochemistry of what's going on. Actually, unless we have had a new research project, such as the home program, we have not added a patient to
our program in over two years. In contrast, of course, the new center downtown now carries 13 patients and is
about to go up to 30, so the statement
that there are fewer patients being
benefited by chronic dialysis is simply
a function of economics. If we had the
money, we could take everybody in
King County and we think we are
going to be able to do this soon with
the combination of the center and the
home program. One or two other
points. To say that 80% of all twins
done are now alive is not necessarily
contradicting the statement that 70%
of the twins who could have survived
five years are now dead.
Dr. Hume: This statement is incorrect.
Dr. Scribner: This was the statement that Don Thomas got from the
group in Boston about two weeks ago.
I do believe that chronic dialysis, based
on our experience, is an accepted
method of treatment. This is borne out
by the world survey that we have just
conducted. In this survey we asked,
"can any well-trained internist, if he
wants to, maintain a patient on chronic
dialysis?", and all 20 investigators
said yes. So, chronic dialysis is no
longer an experimental technique; it is

a therapeutic technique available to
anyone who wants to get in, roll up
his sleeves, and go to work. The problem is that we need time to activate
the units, we need money, and proper
facilities. And, incidentally, with all
due respect to the excellent program
here (at the Medical College of Virginia), they do not have proper facilities for chronic dialysis on an outpatient basis. The chronic dialysis
program here is solely for the support
of the excellent transplant research
program that is going on.
Dr. Doolan (to Dr. Hume): You
mentioned something about someone
overpowering someone. I would find it
hard for anybody to overpower you,
Dave. There really wasn't any argument the way you wound it up, in
that nobody argues with the ultimate
desirability of having an intact kidney
in you. But, let me ask you, how many
transplants with non-maternal donors
have survived over a year?
Dr. Hume: Of the patients that
started off with a non-maternal kidney
that could have survived more than a
year, there were two, and they are
both alive. Of the patients that have
received cadaver kidneys, an unrelated
group, 70% are still alive.
Dr. Doolan: After one year?
Dr. Hume: No, because they haven't
all been a year.
Dr. Doolan: Dave, will you make
the statement here and now that you,
a surgeon, can guarantee a more than
one-year survival of 50 or 70% in unrelated homotransplants?
Dr. Hume: Of course not, that
would be a ridiculous statement to
make.
Dr. Doolan: Well, boy, you threw
around an awful lot of statistics. I don't
know whether you are talking about
two weeks, two months, or what.
Dr. Hume: Well, I think the most
important figures in this regard are
that if you take the patients who have
been done more than a year ago, who
are still living at the present time, so
that all of these patients are from one
to two years, and are patients who
couldn't have lived more than a year,
46% of them are living.
Dr. Doolan: Would you give me that
once more? I'm a little slow.
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Dr. Hume: Yes. Take the patients
done in the first year of our program.
Our program began August, 1962. All
those patients are now from one to two
years from their transplant. Now take
all the patients who could have lived
during that time-there were 13 such
cases who were done during that year
-six of those patients are now living,
which is 46% of the group. If you
take those patients who have now been
one year, which is not quite the first
year, all told, 44% of patients who
could have lived during that year are
now living.
Dr. Doolan: I would only say that,
as far as I know, unrelated transplants
is strictly an investigative technique
and if you select your patients well,
from what I know of the Seattle group,
it's a therapeutic technique. So, the
only position I'm left with here is
wondering why you have the sensitivity you do in the first place.
Dr. Hume: I have no particular sensitivity. I think that the figures do represent the facts as they are now. I think
it's important to feel that transplantation results are good enough to justify
any investigation on this program. And
I think it's good that the results of
hemodialysis are not so good that one
should settle for this type of therapeutic regimen at the present time.
That's all.
Dr. Scribner: I don't wish to give up
keeping score here, but could I take
advantage of this situation to ask you
to comment on what the fundamental
improvements have been in the technique of transplantation in the past
year or two. I have a feeling that
things are improving.
Dr. Hume: I think the thing we've
perhaps observed better than before
are, first of all, that at the first indication of rejection, immunosuppressive
therapy is increased. Secondly, I think
the use of local radiation has helped
and I think this may be one of the
reasons that our cadaver transplants
are coming along better than some.
This is something that has come out of
the laboratory that seems to help clinically. Thirdly, the use of prednisone
has been extremely valuable in preventing rejection. Fourthly, the preparation of patients for surgery by the
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types of chronic dialysis now available
is vastly better. We started off with
peritoneal dialysis and now we use the
Scribner technique. Fifthly, I think that
keeping the patients on hand longer
has given us the time to observe them
and manage them better after transplant.
Dr. Doolan: May I make one more
comment in a different vein, Dave, and
that touches on statistics. I recommended for the military section of the
AMA that the treatment of post-traumatic renal insufficiency should be
prophylactic hemodialysis a la Seattle
group technique, which I think is the
finest available. The way I justify this
statistically is that Scribner and Bob
Hagstrom are the only ones that have
lowered mortality rate in acute renal
insufficiency in the post-traumatic
group. To the best of my knowledge,
that's where the issue stands statistically at the moment.
Dr. Scribner: I'm terribly biased in
this regard, but I feel that the prophylactic approach to acute renal failure
just makes eminent good sense as Paul
just very well stated, and since dialysis
in a properly-run center such as you
have here in Richmond is virtually
without risk, and uremia is dangerous
to a person with fractures and so on,
it just is the only way to do it.
Dr. Hume: Thank you very much
for your kind attendance.

"The basic texture of research
consists of dreams into which the
threads of reasoning, measurement,
and calculation are woven".
Albert Szent-Gyorgyi, Introduction to a Submolecular Biology.
New York and London: Academic
Press, 1960, p 1.

